ASH News Daily 2017 - Issue 3 - A-18
MON 2017
ASHN
News
ewSD
Daily
Aily
ASH
PageA-18
B-6
Page
Sunday,December
December11,
9, 2017
2012
Monday,
®
ASH Live: Today's Remote Session Viewing Schedule
ASH Central: Hall B1
7:00 -
8:30 a.m.
9:00 -
10:00 a.m.
10:30 a.m.
- Noon
12:15 -
1:15 p.m.
626. Aggressive
Lymphoma
(Diffuse Large
B-Cell and
Other Aggressive
B-Cell NonHodgkin
Lymphomas)
E. Donnall
Thomas Lecture
and Prize
624. Hodgkin
Lymphoma and
T/NK Cell
Lymphoma-
Clinical Studies:
Hodgkin
Lymphoma
Immunotherapy Studies
Emerging
Issues in Clinical
Care in
Thalassemia
Channel 3
Channel 4
1:30 -
2:30 p.m.
2:45 -
4:15 p.m.
4:30 -
6:00 p.m.
6:15 -
7:45 p.m.
Global
Hematology
Symposium
624. Hodgkin
Lymphoma
and T/NK Cell
Lymphoma-
Clinical Studies: Hodgkin
Lymphoma
624. Hodgkin
Lymphoma and
T/NK Cell Lymphoma-Clinical Studies
508. Bone
Marrow Failure:
Inherited Bone
Marrow
Failure
622.
Lymphoma
Biology-NonGenetic
Studies:
Featured Topic:
Combination
Therapies: How
Are We
Deciding What
to Utilize?
622.
Lymphoma
Biology-
Non-Genetic
Studies
603. Oncogenes and
Tumor Suppressors: Epigenetic
and PostTranscriptional
Control
904. Outcomes
Research-
Malignant C
onditions
801. Gene
Therapy and
Transfer
203.
Lymphocytes,
Lymphocyte
Activation, and
Immunodeficiency
ASH Choosing
Ernest Beutler
Lecture and Prize
Wisely®
Campaign:
2017 ASH
Choosing Wisely
Champions
203. Lymphocytes, Lymphocyte Activation,
and Immunodeficiency
602. Disordered Gene
Expression in
Hematologic
Malignancy
721. Clinical Allogeneic
Transplantation
201. Granulocytes, Monocytes, and
Macrophages:
SCN
Acute
Lymphocytic
Leukemia: New
Approaches in
Management
653. Myeloma:
Therapy, excluding Transplantation I
653. Myeloma:
Therapy, excluding Transplantation
Dilemmas in
Pediatric
Hematologic
Malignancy
Hodgkin Lymphoma: New
Insights and
New Approaches
Novel Therapeutics in
Myeloma
ASH-FDA Joint
Symposium
on New Drug
Approvals in
Acute Myeloid
Leukemia
603. Oncogenes
and Tumor Suppressors
Individualizing
Therapy in
Chronic
Lymphocytic
Leukemia
Controversies in
Myeloma
Evolving
Strategies in
Aggressive BCell Lymphoma
614. Acute
Lymphoblastic
Leukemia: Therapy, excluding
Transplantation
653. Myeloma:
Therapy,
excluding Transplantation II
Acute Myeloid
Leukemia:
How Can We
Improve Upon
"Standard"
Therapy?
721. Clinical
Allogeneic
Transplantation:
721. Clinical
Allogeneic
Transplantation
732. Clinical
Allogeneic
Transplantation
632. Chronic
Myeloid Leukemia: Therapy:
Results of Clinical Trials
602. Disordered
Gene
Expression in
Hematologic
Malignancy
904. Outcomes
Research-
Malignant
Conditions
401. Basic
Science and
Clinical Practice
in Blood Transfusion
401. Basic
Science and
Clinical Practice
in Blood Transfusion
612. Acute
Lymphoblastic
Leukemia
637. Myelodysplastic
Syndromes-
Clinical Studies:
Genes Inform
Genes
901. Health
Services
Research-NonMalignant
Conditions
903. Outcomes
Research-NonMalignant
Conditions:
Health Impact
and Mortality
903. Outcomes
Research-NonMalignant Conditions: Sickle
Cell Disease
Channel 10
613. Acute
Myeloid
Leukemia
The Challenge
of Primary and
Secondary
Central Nervous
System
Lymphoma
When Graft
Versus Tumor
Fails
627. Aggressive Lymphoma
(Diffuse Large B
Cell and Other
Aggressive B Cell
Non-Hodgkin
Lymphomas)
Channel 11
Therapeutic
Apheresis as an
Immunomodulatory Tool
613. Acute Myeloid Leukemia:
Novel Therapies
for AML and
APL
616. Acute Myeloid Leukemia:
Novel Therapy,
excluding
Transplantation
616. Acute Myeloid Leukemia:
Novel Therapy,
excluding
Transplantation
When Graft
Versus Tumor
Fails
Myelodysplastic
Syndromes:
Understanding
the Current
Treatment
Landscape
Myeloproliferative Neoplasms:
New Insights
in the Current
Treatment Paradigm
642. CLL: Therapy, excluding
Transplantation:
New Agents,
Infections, and
PET/CT
Channel 1
Channel 2
Channel 5
Channel 6
Channel 7
Channel 8
Channel 9
Channel 12
616. Acute
Myeloid
Leukemia:
Novel Therapy,
excluding
Transplantation
Table of Contents for the Digital Edition of ASH News Daily 2017 - Issue 3
ASH News Daily 2017 - Issue 3 - A-1
ASH News Daily 2017 - Issue 3 - A-2
ASH News Daily 2017 - Issue 3 - A-3
ASH News Daily 2017 - Issue 3 - A-4
ASH News Daily 2017 - Issue 3 - A-5
ASH News Daily 2017 - Issue 3 - A-6
ASH News Daily 2017 - Issue 3 - A-7
ASH News Daily 2017 - Issue 3 - A-8
ASH News Daily 2017 - Issue 3 - A-9
ASH News Daily 2017 - Issue 3 - A-10
ASH News Daily 2017 - Issue 3 - A-11
ASH News Daily 2017 - Issue 3 - A-12
ASH News Daily 2017 - Issue 3 - A-13
ASH News Daily 2017 - Issue 3 - A-14
ASH News Daily 2017 - Issue 3 - A-15
ASH News Daily 2017 - Issue 3 - A-16
ASH News Daily 2017 - Issue 3 - A-17
ASH News Daily 2017 - Issue 3 - A-18
ASH News Daily 2017 - Issue 3 - A-19
ASH News Daily 2017 - Issue 3 - A-20
ASH News Daily 2017 - Issue 3 - A-21
ASH News Daily 2017 - Issue 3 - A-22
ASH News Daily 2017 - Issue 3 - A-23
ASH News Daily 2017 - Issue 3 - A-24
ASH News Daily 2017 - Issue 3 - A-25
ASH News Daily 2017 - Issue 3 - A-26
ASH News Daily 2017 - Issue 3 - A-27
ASH News Daily 2017 - Issue 3 - A-28
ASH News Daily 2017 - Issue 3 - B-1
ASH News Daily 2017 - Issue 3 - B-2
ASH News Daily 2017 - Issue 3 - B-3
ASH News Daily 2017 - Issue 3 - B-4
ASH News Daily 2017 - Issue 3 - B-5
ASH News Daily 2017 - Issue 3 - B-6
ASH News Daily 2017 - Issue 3 - B-7
ASH News Daily 2017 - Issue 3 - B-8
ASH News Daily 2017 - Issue 3 - B-9
ASH News Daily 2017 - Issue 3 - B-10
ASH News Daily 2017 - Issue 3 - B-11
ASH News Daily 2017 - Issue 3 - B-12
ASH News Daily 2017 - Issue 3 - B-13
ASH News Daily 2017 - Issue 3 - B-14
ASH News Daily 2017 - Issue 3 - B-15
ASH News Daily 2017 - Issue 3 - B-16
ASH News Daily 2017 - Issue 3 - B-17
ASH News Daily 2017 - Issue 3 - B-18
ASH News Daily 2017 - Issue 3 - B-19
ASH News Daily 2017 - Issue 3 - B-20
ASH News Daily 2017 - Issue 3 - B-21
ASH News Daily 2017 - Issue 3 - B-22
ASH News Daily 2017 - Issue 3 - B-23
ASH News Daily 2017 - Issue 3 - B-24
ASH News Daily 2017 - Issue 3 - B-25
ASH News Daily 2017 - Issue 3 - B-26
ASH News Daily 2017 - Issue 3 - B-27
ASH News Daily 2017 - Issue 3 - B-30
ASH News Daily 2017 - Issue 3 - B-31
ASH News Daily 2017 - Issue 3 - B-32
ASH News Daily 2017 - Issue 3 - B-33
ASH News Daily 2017 - Issue 3 - B-34
ASH News Daily 2017 - Issue 3 - B-35
ASH News Daily 2017 - Issue 3 - B-36
ASH News Daily 2017 - Issue 3 - B-37
ASH News Daily 2017 - Issue 3 - B-38
ASH News Daily 2017 - Issue 3 - B-39
ASH News Daily 2017 - Issue 3 - B-40
ASH News Daily 2017 - Issue 3 - B-41
ASH News Daily 2017 - Issue 3 - B-42
ASH News Daily 2017 - Issue 3 - B-43
ASH News Daily 2017 - Issue 3 - B-44
ASH News Daily 2017 - Issue 3 - B-45
ASH News Daily 2017 - Issue 3 - B-46
ASH News Daily 2017 - Issue 3 - B-47
ASH News Daily 2017 - Issue 3 - B-48
ASH News Daily 2017 - Issue 3 - B-49
ASH News Daily 2017 - Issue 3 - B-50
ASH News Daily 2017 - Issue 3 - B-51
ASH News Daily 2017 - Issue 3 - B-52
ASH News Daily 2017 - Issue 3 - B-53
ASH News Daily 2017 - Issue 3 - B-54
ASH News Daily 2017 - Issue 3 - B-55
ASH News Daily 2017 - Issue 3 - B-56
ASH News Daily 2017 - Issue 3 - C-1
ASH News Daily 2017 - Issue 3 - C-2
ASH News Daily 2017 - Issue 3 - C-3
ASH News Daily 2017 - Issue 3 - C-4
ASH News Daily 2017 - Issue 3 - C-5
ASH News Daily 2017 - Issue 3 - C-6
ASH News Daily 2017 - Issue 3 - C-7
ASH News Daily 2017 - Issue 3 - C-8
ASH News Daily 2017 - Issue 3 - C-9
ASH News Daily 2017 - Issue 3 - C-10
ASH News Daily 2017 - Issue 3 - C-11
ASH News Daily 2017 - Issue 3 - C-12
ASH News Daily 2017 - Issue 3 - C-13
ASH News Daily 2017 - Issue 3 - C-14
ASH News Daily 2017 - Issue 3 - C-15
ASH News Daily 2017 - Issue 3 - C-16
ASH News Daily 2017 - Issue 3 - C-17
ASH News Daily 2017 - Issue 3 - C-18
ASH News Daily 2017 - Issue 3 - C-19
ASH News Daily 2017 - Issue 3 - C-20
ASH News Daily 2017 - Issue 3 - C-21
ASH News Daily 2017 - Issue 3 - C-22
ASH News Daily 2017 - Issue 3 - C-23
ASH News Daily 2017 - Issue 3 - C-24
ASH News Daily 2017 - Issue 3 - C-25
ASH News Daily 2017 - Issue 3 - C-26
ASH News Daily 2017 - Issue 3 - C-27
ASH News Daily 2017 - Issue 3 - C-28
ASH News Daily 2017 - Issue 3 - C-29
ASH News Daily 2017 - Issue 3 - C-30
ASH News Daily 2017 - Issue 3 - C-31
ASH News Daily 2017 - Issue 3 - C-32
https://www.nxtbookmedia.com